|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003873,
umls-concept:C0008976,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0087111,
umls-concept:C0205390,
umls-concept:C0205412,
umls-concept:C0231491,
umls-concept:C1274040,
umls-concept:C2351058,
umls-concept:C2612728
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2011-6-30
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
To assess the efficacy, safety, and biologic activity of atacicept in patients with rheumatoid arthritis (RA) in whom the response to treatment with tumor necrosis factor antagonists was inadequate.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1529-0131
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2011 by the American College of Rheumatology.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
63
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1793-803
|
|
pubmed:meshHeading |
pubmed-meshheading:21452293-Adult,
pubmed-meshheading:21452293-Aged,
pubmed-meshheading:21452293-Antirheumatic Agents,
pubmed-meshheading:21452293-Arthritis, Rheumatoid,
pubmed-meshheading:21452293-Dose-Response Relationship, Drug,
pubmed-meshheading:21452293-Double-Blind Method,
pubmed-meshheading:21452293-Female,
pubmed-meshheading:21452293-Humans,
pubmed-meshheading:21452293-Immunoglobulins,
pubmed-meshheading:21452293-Intention to Treat Analysis,
pubmed-meshheading:21452293-Male,
pubmed-meshheading:21452293-Middle Aged,
pubmed-meshheading:21452293-Recombinant Fusion Proteins,
pubmed-meshheading:21452293-Rheumatoid Factor,
pubmed-meshheading:21452293-Treatment Outcome,
pubmed-meshheading:21452293-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: results of a phase II, randomized, placebo-controlled, dose-finding trial.
|
|
pubmed:affiliation |
Stanford University, Palo Alto, California, USA. genovese@stanford.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
